Home › Austin biotech firm seeks $15M on Wall Street to continue fight against cancer
 

Keywords :   


Austin biotech firm seeks $15M on Wall Street to continue fight against cancer

2015-07-14 22:18:24| Biotech - Topix.net

The Austin-based health diagnostics company focused on tests for ovarian cancer has priced a common stock offering of 8.35 million shares at $1.96 per share, the company said Tuesday. Net proceeds are expected to be about $15.2 million.

Tags: street continue firm wall

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.05Insulation scandal: I have to scrape mould off the walls every two weeks'
29.05Eastern North Pacific Tropical Weather Outlook
29.05Atlantic Tropical Weather Outlook
29.05PM pledges to swap 'rip-off' degrees for apprenticeships
28.05Central Stockyards adds team members, prepares for Canadian expansion
28.05Life happens for us, not to us
28.05Kansas State University receives $25M matching award from Kansas Legislature
28.05Dalim Software unveils new workflow solutions at drupa
More »